LexDanaLexDanabeta
Inventor

Rachel Cathleen Botham

Inventor
US

Overview

4→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 4 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C12NMicroorganisms or enzymes22%
C12YEnzymes22%
Y02EReduction of greenhouse gas [ghg] emissions, related to energy generation, transmission or distribution11%
PatentTitleYear
12,497,605Engineered acid alpha-glucosidase variants202512,286,655Human alpha-galactosidase variants202511,970,722Engineered acid alpha-glucosidase variants202411,427,813Human alpha-galactosidase variants2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2024Patents assigned to CODEXIS INC (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to CROSSWALK THERAPEUTICS INC (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CODEXIS INC22022–2024
CROSSWALK THERAPEUTICS INC22025
Locations
LocationPatentsSpan
US42022–2025